Anthem Biosciences, which closed its IPO bidding on July 16, is set to make its stock market debut on Monday, July 21, 2025. According to market observers, the IPO is likely to list strongly, with grey market premium (GMP) suggesting gains of over 23%.

The IPO was open for subscription from July 14 to July 16, and share allotment was finalized on Thursday, July 17. The shares will be listed on both BSE and NSE.

Key IPO details:

  • IPO price band: ₹570 per share

  • Retail minimum lot size: 26 shares (₹14,040)

  • sNII minimum lot: 364 shares (₹2,07,480)

  • bNII minimum lot: 1,768 shares (₹10,07,760)

  • Employee reservation: Up to 1,58,654 shares at a ₹50 discount

  • Book-running lead manager: JM Financial

  • Registrar: KFin Technologies

GMP indicates a strong debut

According to Investorgain.com, the Anthem Biosciences IPO GMP was ₹132 as of 9:56 AM on July 19, implying an estimated listing price of ₹702 per share — a potential gain of about 23.16% over the issue price.
A day earlier on July 18, the GMP peaked at ₹144, indicating an estimated listing price of ₹714, or around 25.26% gains.

How to check your IPO allotment?

You can check the allotment status through the following platforms:

On KFin Technologies website:

  1. Visit KFin Technologies’ IPO allotment page.

  2. Select “Anthem Biosciences Limited” from the company dropdown.

  3. Enter either your PAN or Application Number.

  4. View your allotment status.

On NSE:

  1. Go to: NSE IPO Allotment page

  2. Select “Equity & SME IPO bid details”.

  3. Enter your PAN and Application Number.

  4. Submit to check your status.

On BSE:

  1. Visit BSE IPO Allotment page.

  2. Select “Equity” as issue type and “Anthem Biosciences IPO” from the list.

  3. Enter your Application Number or PAN.

  4. Click search to view your allotment status.

Hold or exit?

With a GMP suggesting a premium of over 23%, many investors expect a positive debut for Anthem Biosciences. However, GMP is not an assured indicator of listing day performance, and investors are advised to assess fundamentals and risk appetite before deciding whether to hold or book profits at listing.

Disclaimer: The information above is based on publicly available sources and grey market data, which is unofficial and speculative. Investors should make informed decisions after consulting with financial advisors.

Follow on Google News